Access to MS Medications Bills Advance to President
On
In recent years it has become apparent that consumers may be paying more than the actual cost of their medication (the price negotiated by the PBM) at the pharmacy. Pharmacists who violated the contract with PBMs could have been penalized with fees or pulled from the network. This issue tends to affect access to symptom-management medications, which people living with MS may commonly purchase via a local pharmacy, more than disease-modifying therapies.
2019 Individual and Small Group Health Insurance Rates Announced
Progress on Income and Poverty Continued Into 2017 But Abruptly Halted on Health Coverage, Census Data Show
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News